Get in Touch

Jun 26, 2019

Corporate India

Q4 FY12 Results - A Curtain Raiser

05/17/2012 9:00 PM | Thursday |
The March quarter results, which are keenly awaited by the investors and market watchers, have failed to bring any cheer.

Top Ten On Institutional Investors

05/11/2012 9:00 PM | Friday | By DSIJ Team
Which company ranks at the top when it comes to institutional investment? Take a look at the list of most favoured top 10 investment option for institutional investors.

March Industrial Output Falls To Negative 3.5 Per Cent

05/11/2012 6:21 PM | Friday | By Prabhat Anantharaman

After growing by 4.1 per cent in the month of February 2012, the March Index of Industrial Production (IIP) has surprisingly contracted to negative 3.5 per cent.

Strides Arcolab May Sell Domestic Generics Business

05/09/2012 3:18 PM | Wednesday | By Shrikant Akolkar
News papers have reported that Strides Arcolab is in talks to sell its India generics business to Zydus Cadila. Company has denied any such news. We believe that the sale of domestic business will have negligible impact on its revenues.

Bring Up Public Holdings

05/03/2012 9:00 PM | Thursday |
The SEBI has directed all listed entities to ensure that they bring up their public shareholding to a minimum of 25 per cent. While the move is good to ensure a liquid and more better price discovery for stock prices, there are difficulties that companies are likely to face while adhering to the norm.

Do FIIs Stoke Share Prices?

05/03/2012 9:00 PM | Thursday |
FIIs have long been believed to be the backbone of the Indian stock market. Does their interest or otherwise really matter to share price movements? Evidence suggests, they actually don’t .

Top Ten Companies By Market Cap Value

04/27/2012 9:00 PM | Friday | By DSIJ Team
Market capitalization is calculated by multiplying the number of outstanding shares with the closing price of the stock on major bourse. Here is the list of top 10 Indian companies by market capitalisation as of April 2012.

Indian Pharma Companies Do Well With Generic Boom

04/23/2012 6:12 PM | Monday | By Shrikant Akolkar
Indian pharma companies are seen launching big ticket generic drugs in US. The market of generic drugs will witness handsome growth opportunities in future and we believe that Indian pharma companies are well placed to grab the same.

The Whys And Wherefores Of RBI's Aggression

04/19/2012 9:00 PM | Thursday |

The RBI has cut key interest rates by a good 50 basis points against a consensus estimate and expectations of around 25 basis points, putting economic growth ahead of other parameters. What has prompted it to do so? Vidrum Mehta provides some clues.

Indian PSU Sector Looking Beyond

04/05/2012 9:00 PM | Thursday |
«« First |1 2 3 4 5 6 7 8 9 10 | Last ››

Top 10 companies with Lowest Foreign Institutional Investors (FIIs) Holding in BSE 100 Companies



(* No Research/Stock Queries)
Name :
Email ID :
Cell Number :
Message :